Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

A vaccine to prevent epidemic meningitis in Africa.

Viviani S.

Lancet Infect Dis. 2013 Mar;13(3):195-6. doi: 10.1016/S1473-3099(13)70010-0. No abstract available.

PMID:
23427886
2.

Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data.

Novak RT, Kambou JL, Diomandé FV, Tarbangdo TF, Ouédraogo-Traoré R, Sangaré L, Lingani C, Martin SW, Hatcher C, Mayer LW, Laforce FM, Avokey F, Djingarey MH, Messonnier NE, Tiendrébéogo SR, Clark TA.

Lancet Infect Dis. 2012 Oct;12(10):757-64. doi: 10.1016/S1473-3099(12)70168-8.

3.

Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso--implications for introduction of PsA-TT into the Expanded Programme on Immunization.

Meyer SA, Kambou JL, Cohn A, Goodson JL, Flannery B, Medah I, Messonnier N, Novak R, Diomande F, Djingarey MH, Clark TA, Yameogo I, Fall A, Wannemuehler K.

Vaccine. 2015 Mar 17;33(12):1492-8. doi: 10.1016/j.vaccine.2015.01.043.

PMID:
25636915
4.

Chronicle of an outbreak foretold: meningococcal meningitis W135 in Burkina Faso.

Decosas J, Koama JB.

Lancet Infect Dis. 2002 Dec;2(12):763-5.

PMID:
12467693
5.

Development of a group A meningococcal conjugate vaccine, MenAfriVac(TM).

Frasch CE, Preziosi MP, LaForce FM.

Hum Vaccin Immunother. 2012 Jun;8(6):715-24. doi: 10.4161/hv.19619. Review.

PMID:
22495119
6.

Vaccine introduction. The beginning of the end for Africa's devastating meningitis outbreaks?

Roberts L.

Science. 2010 Dec 10;330(6010):1466-7. doi: 10.1126/science.330.6010.1466. No abstract available.

PMID:
21148362
7.

Study of a localized meningococcal meningitis epidemic in Burkina Faso: incidence, carriage, and immunity.

Mueller JE, Yaro S, Njanpop-Lafourcade BM, Drabo A, Idohou RS, Kroman SS, Sanou O, Diagbouga S, Traoré Y, Sangaré L, Borrow R, Gessner BD.

J Infect Dis. 2011 Dec 1;204(11):1787-95. doi: 10.1093/infdis/jir623.

8.

Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccines.

Robbins JB, Schneerson R, Gotschlich EC, Mohammed I, Nasidi A, Chippaux JP, Bernardino L, Maiga MA.

Bull World Health Organ. 2003;81(10):745-50; discussion 751-5.

9.

Serogroup A meningococcal conjugate vaccine coverage after the first national mass immunization campaign-Burkina Faso, 2011.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2012 Dec 21;61(50):1022-4.

10.

Meningococcal disease control in countries of the African meningitis belt, 2013.

[No authors listed]

Wkly Epidemiol Rec. 2014 May 16;89(20):206-14. English, French. No abstract available.

11.

Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.

Mueller JE, Borrow R, Gessner BD.

Expert Rev Vaccines. 2006 Jun;5(3):319-36. Review.

PMID:
16827617
12.

[Meningococcal meningitis epidemics in sub-Saharan Africa and the meningococcal A conjugate vaccine].

Nicolas P.

Med Sante Trop. 2012 Jul-Sep;22(3):246-58. doi: 10.1684/mst.2012.0086. French.

13.

Response thresholds for epidemic meningitis in sub-Saharan Africa following the introduction of MenAfriVac®.

Trotter CL, Cibrelus L, Fernandez K, Lingani C, Ronveaux O, Stuart JM.

Vaccine. 2015 Nov 17;33(46):6212-7. doi: 10.1016/j.vaccine.2015.09.107.

PMID:
26463444
14.

Serogroup W Meningitis Outbreak at the Subdistrict Level, Burkina Faso, 2012.

Cibrelus L, Medah I, Koussoubé D, Yélbeogo D, Fernandez K, Lingani C, Djingarey M, Hugonnet S.

Emerg Infect Dis. 2015 Nov;21(11):2063-6. doi: 10.3201/eid2111.150304.

15.

Meningococcal carriage in the African meningitis belt.

MenAfriCar Consortium..

Trop Med Int Health. 2013 Aug;18(8):968-78. doi: 10.1111/tmi.12125.

16.

Costs and impact of meningitis epidemics for the public health system in Burkina Faso.

Colombini A, Badolo O, Gessner BD, Jaillard P, Seini E, Da Silva A.

Vaccine. 2011 Jul 26;29(33):5474-80. doi: 10.1016/j.vaccine.2011.05.058.

PMID:
21641952
17.

Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Chad, 2013.

Gamougam K, Daugla DM, Toralta J, Ngadoua C, Fermon F, Page AL, Djingarey MH, Caugant DA, Manigart O, Trotter CL, Stuart JM, Greenwood BM.

Emerg Infect Dis. 2015 Jan;21(1):115-8. doi: 10.3201/eid2101.140256.

18.

Meningococcal meningitis: vaccination outbreak response and epidemiological changes in the African meningitis belt.

Carod Artal FJ.

Int Health. 2015 Jul;7(4):226-7. doi: 10.1093/inthealth/ihv025.

PMID:
25878213
19.

Antipneumococcal seroprevalence and pneumococcal carriage during a meningococcal epidemic in Burkina Faso, 2006.

Yaro S, Njanpop-Lafourcade BM, Drabo A, Idohou RS, Kroman SS, Sanou O, Traoré Y, Sangaré L, Diagbouga SP, Koeck JL, Borrow R, Gessner BD, Mueller JE.

J Infect Dis. 2014 Apr 15;209(8):1241-50. doi: 10.1093/infdis/jit641.

PMID:
24277740
20.

Vaccine offers meningitis hope.

Butler D.

Nature. 2010 Nov 11;468(7321):143. doi: 10.1038/468143a. No abstract available.

PMID:
21068797
Items per page

Supplemental Content

Support Center